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Background
Life-threatening arrhythmias (LTA) such as ventricular fibrillation (VF) are very serious 
conditions that may lead to death in few minutes. VF is characterized by chaotic and 
asynchronous cardiomyocyte electrical activity which leads to ineffective heart pumping 
[1]. It has a prevalence of approximately ~ 25–50% of people with out-of-hospital car-
diac arrest (OHCA) [2–4]. LTA are one of the major causes of death around the world. 
Annually, 35 per 100,000 people experience OHCA globally, including adults and chil-
dren, and this number increases to 62 per 100,000 people when only adults are taken in 
account [5].
Once LTA are diagnosed, a high-intensity electric field (HEF) must be applied in 
the patient as soon as a defibrillator is available in a procedure called defibrillation 
[6]. For effective defibrillation, a critical mass (75–90%) of ventricular cardiomyocytes 
has to be excited at the same time [7]. However, the excitation of this large number 
of cardiomyocytes requires the application of HEF which reaches around 100 V/cm 
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or higher in some regions of the myocardium [8]. A HEF of this magnitude may lead 
to acute myocardial injury by electroporation [9], depression of contractile func-
tion [10] and blockage of electrical conduction by necrosis [11]. Furthermore, our 
research team has already demonstrated that HEF of such intensity is able to kill car-
diomyocytes [12–14]. Nevertheless, even a non-lethal HEF can make the cell unexcit-
able, generating a substrate to arrhythmia re-induction [15]. These side effects might 
be related to the low survival rates reported after OHCA, which have been stable at 
7–8% for the last 30 years despite the improvements in treatment and the increased 
availability of automated external defibrillators (AEDs) in public places [4, 16]. In this 
context, several studies have been carried out with the aim of improving defibrillation 
procedure to increase its success rate whilst reducing its side effects.
Our aim was to show the efficacy of a simple and feasible method able to improve 
the defibrillatory procedure, through the study of the strength–duration (SxD) curves. 
SxD curves have been exhaustively studied for the heart, but for the first time we pre-
sent a paired study with heart pacing SxD curves and defibrillation SxD curves for the 
same hearts; from these data, we also propose a relationship between heart pacing 
electric field (E) and defibrillation HEF as a possible indicator of heart damage risk.
Also, a previous study of our research team has shown that the ratio of lethal HEF 
to excitation threshold for isolated rat cardiomyocytes changes with stimuli duration 
and is maximal for 0.5-ms stimuli [12], which indicates that this duration would prob-
ably be safer for defibrillation. In this study, we confirmed the relationship between 
defibrillation safety and pulse duration through SxD curves. We correlated the 
required HEF intensity for defibrillation with the shock intensity required for heart 
pacing to verify whether the existence of a previously observed optimum duration 
for cardiomyocyte stimulation would be translated to a higher efficiency in rat heart 
defibrillation.
Results
Adult male Wistar rats were euthanized under deep anesthesia and the hearts were 
removed and cannulated in less than 30 s, avoiding physiological function loss due to 
prolonged ischemia [17, 18]. Hearts weighed on average 2.46 ± 0.07 g.
Pacing threshold
Pacing strength–duration (SxD) curve (Fig. 1) shows the correlation between the stim-
ulatory pulse duration and the mean pacing threshold (ET). The SxD curve was well 
adjusted by the Weiss–Lapicque equation (Eq. 1, R2 = 0.96), where Y is the HEF intensity 
corresponding to a pulse duration d, Erh is the rheobase value (field modulus when d is 
infinity) and cr is the chronaxie (pulse duration corresponding to twice the rheobase). 
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Defibrillation probability curves
Figure 2 shows the defibrillation probability curves as a function of the applied HEF in 
V/cm for all tested durations. These curves are significantly different (p < 0.0001). When 
compared in pairs, the 0.2-ms curve was different from all the others, whilst 0.5-ms and 
1-ms curves were similar but different from all other curves. The average values of HEF 
corresponding to 50% of defibrillation probability  (HEF50) values in V/cm were obtained 
from the nonlinear fit of the survival test results (Fig.  2) and were significantly differ-
ent from each other (p < 0.0001). The  HEF50 of curves with duration of 0.2-, 0.5-, 1- and 
3-  ms was different from all the others. On the other hand, 5-, 8- and 10-ms curves 
presented very close  HEF50 values with no significant differences between them. Then 
the increase in the defibrillatory pulse duration beyond 5-ms did not promote intensity 
reduction of the shocks required for defibrillation. The adjustment of these  HEF50 val-
ues by the Weiss–Lapicque equation generated a defibrillation SxD curve (Fig. 3) with 
rheobase and chronaxie of the 4.17 ± 0.561 V/cm and 1.41 ± 0.235 ms, respectively. 
Fig. 1 Pacing strength–duration curve. R2 = 0.9609 (Weiss–Lapicque equation). Circles indicate the mean 
pacing threshold (ET) and the vertical lines indicate standard error of the mean (SEM). Curve was fitted by 
Eq. (1) (rheobase = 0.16 ± 0.01 V/cm, chronaxie = 1.820 ± 0.20 ms), n = 10
Fig. 2 Defibrillation probability as a function of the applied electric fields (V/cm). Vertical lines indicate the 
standard error of the mean (SEM). a Curves of the durations 0.2-; 0.5- and 1-ms. b Curves of durations 3-, 5-, 
8- and 10-ms. Curves were fitted by Eq. (3), n = 10, each heart was defibrillated seven times (one time for each 
pulse duration)
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Ratio of defibrillation probability to pacing threshold
The  HEF50 obtained from the probability curves (Fig. 4) for each pulse duration is shown 
in Fig. 5. This graphical representation puts emphasis on how greater than the pacing 
threshold a shock should be to succeed in defibrillation. In general, the  HEF50 was over 
20 times the threshold (×Threshold), the only exception was the 0.5-ms pulses, which 
 HEF50 was 17.65 ×Threshold. Normalized  HEF50 were different (p < 0.001) and when 
compared in pairs, the 0.2-ms pulse was not different from 0.5-ms and 3-ms pulses, but 
it was different from all the others. 1-ms pulse was different from the 3-ms, and 3-ms 
was different from the 8-ms pulse. The  HEF50 values of the sigmoid adjustment were 
also significantly different (p < 0.001). When compared in pairs, the  HEF50 of the 0.5-ms 
curve (the only one below 20 ×Threshold) is different from all others. There was no dif-
ference in the comparison between the  HEF50 of the 0.2-ms and 3-ms curves, between 
the 1-ms and 5-ms curves, and the 8-ms and 10-ms curves. 
To better understand this last result, we normalized the SxD curves (SxD for pacing—
Fig. 1, and SxD for defibrillation—Fig. 3) to their respective rheobase (Fig. 6). For dura-
tions of 10-, 8-, 5-, 3- and 1-ms, the values of rheobase normalized ET and  HEF50 are 
Fig. 3 Defibrillation probability strength–duration curve. R2 = 0.9885 (Weiss–Lapicque equation). Points 
indicate the electric field associated with 50% of defibrillation success  (HEF50) and the vertical lines 
indicate the confidence interval for 95%. Curve was fitted by Eq. (1) (rheobase = 4.17 ± 0.561 V/cm, 
chronaxie = 1.41 ± 0.235 ms), n = 10, each heart was defibrillated seven times (one time for each pulse 
duration)
Fig. 4 Curves obtained from the sigmoidal adjustment of the normalized defibrillation probability result as 
a function of the electric field (×Threshold). Vertical lines indicate standard error of the mean (SEM). a Curves 
of the durations 0.2-, 0.5- and 1-ms. b Curves of durations 3-, 5-, 8- and 10-ms. Curves were fitted by Eq. (3), 
n = 10
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similar. For durations below 3-ms, we observed that not only both ET and  HEF50 values 
increase, but also the difference between them. For 1- to 0.5-ms, the  HEF50 increase was 
smaller (18%) than the ET increase (58%). For 0.5- to 0.2-ms, both  HEF50 and ET val-
ues increased similarly, about 104% and 134%, respectively; therefore, the  HEF50/ET ratio 
is lower for 0.5-ms since the ET variation is greater than the  HEF50 for this duration, 
whereas it is not so pronounced for the others.
Discussion
The present study shows that, within certain limits, the longer the pulse duration is, the 
lower is the threshold intensity for pacing and defibrillation, as expected for the stimu-
lation of excitable tissues [19, 20]. Herein, we show for the first time, to the best of our 
knowledge, the stimulation and defibrillation SxD curves for the same hearts, consider-
ing an applied E homogeneously, which generated values more reliable and preparation 
independent.
We observed the same behavior for SxD curves for pacing and for defibrillation. Pac-
ing requires a small pulse strength to be successful, because when a small number of 
cells are excited, the action potential propagation occurs throughout the heart [21]. 
Thus, only a small number of cells need to be submitted to a supra-threshold E. In con-
trast, for defibrillation, a simultaneous excitation of a large portion of the myocardium 
Fig. 5 Pacing threshold and defibrillation probability relationship. The bars indicate the mean value of  HEF50 
normalized by the pacing threshold and the vertical lines indicate the confidence interval for 95%, n = 10
Fig. 6 Ratio of ET and  HEF50 to rheobase. The value of  HEF50 to 0.5-ms varied less than ET regarding to 
rheobase, n = 10
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(75–90%) [7] is required to make the cells non-excitable for a period and to terminate 
the fibrillatory mechanisms.
During the E application, non-uniform potential gradient formation happens because 
the cardiac tissue is anisotropic, composed by muscle fibers oriented in multiple direc-
tions with layers of connective tissue [22, 23]. Also, the heart region subjected to a 
higher potential gradient is closer to the electrodes; consequently, this region is eas-
ily stimulated, while other regions might not be stimulated depending on the applied 
E strength. However, when a critical mass of cardiomyocytes must be depolarized at 
the same time, as in the case of defibrillation, E has to be increased to stimulate cells 
which are not close to the electrodes; as a result, defibrillatory E is much larger than 
ET [21, 24]. In addition, pacing occurs during diastole, when most ventricular myocytes 
are relaxed in a vulnerable period. However, during defibrillation, the myocytes are not 
synchronized, each group of cells may be in a different action potential phase, requiring 
even higher amplitudes to excite cells during their relative refractory period and then 
terminate the fibrillation wave fronts [22, 24]. Hence, during defibrillation, the closest 
regions to the electrodes are exposed to a much higher E than the ET. The transmem-
brane potential variation (ΔVm) of each myocyte is proportional to the applied E mod-
ule [25], then the maximal ΔVm is observed in the near-electrode myocytes; moreover, 
during threshold pacing, we may assume that the maximal ΔVm in the myocytes of this 
region is the stimulation threshold (ΔVmT); as a result, it is constant and does not change 
according to stimuli duration [26]. During defibrillation, the ΔVm can be expressed by 
 HEFdefibrillatory/ET multiplied by the ΔVmT, where  HEFdefibrillatory is the high-intensity elec-
tric field necessary to successful defibrillation, which means that the  HEFdefibrillatory/ET 
could be taken as an indirect index of the induced ΔVm in the cardiomyocytes during 
defibrillation. This information is very important because it allows to infer which dura-
tion induced a lower ΔVm, since a high ΔVm may lead to electroporation and consequent 
cell death [27, 28]. We observed a lower  HEFdefibrillatory/ET ratio (17.65) when we defi-
brillated with 0.5-ms pulses. Thus, using this pulse duration, the induced ΔVm in the 
cardiomyocytes was probably lower and, consequently, it may be safer to be used in defi-
brillation procedures.
Defibrillatory pulses with duration of 0.5-ms are probably better for defibrillating rat 
hearts since not only the  HEF50 in ×Threshold is smaller, but cells are also less suscepti-
ble to injury for this duration [12]. Although the defibrillation success × pulse duration 
depends on the animal study [24, 29], the use of a short pulse duration might improve 
defibrillation procedures in human hearts, as Semenov et al. [30] also argued, since the 
commercial defibrillators use pulses with 5- or 10-ms duration, i.e., near the rheobase 
[21, 22]. Despite the difference in heart size between rodents and human, a factor that 
can influence the cardiac arrest mechanisms [31], models using rodent hearts have sev-
eral advantages as presented by Patten et al. [32]. These models, such as the one used in 
this study, produce results that cannot be directly related to the clinical context, but that 
generate important results, especially on the understanding, diagnosis and treatment of 
conditions such as VF because of the unavailability of studies on human subjects for eth-
ical reasons. However, due to the limitations of the models, for results of basic science to 
be translated into clinical practice, studies in larger mammals, whose heart size is more 
similar to that of humans, are needed.
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A possible limitation of this work was the time between heart removal and cannula-
tion finalization (30 s). However, it was not sufficient to cause ischemia impairment in 
previous studies [17, 18]; additionally, contractile and chronotropic impairment may be 
present due to prolonged experiment time and cumulative effect of consecutive shocks.
Despite the fact that the rat hearts were placed in a Langendorff-adapted preparation 
for a maximum time of 3  h and that this type of preparation leads to contractile and 
chronotropic function deterioration of the heart ranging from 5 to 10% per hour [17], 
we believe that the randomized choice of the pulse duration sequence could minimize 
changes in the outcomes that were implied by this deterioration. However, we did not 
note any significant change in the heart function during the experiments involving all 
hearts included in this work.
We hope that this work can bring important clinical implications in the future, lead-
ing to an optimization of commercial defibrillators only by changing the pulse duration. 
A simple reduction of the shock duration, even on a small scale, may possibly lead to a 
significant increase in the effectiveness of defibrillatory procedures.
Conclusions
Considering our results, it is possible to conclude that defibrillated rat hearts by 0.5-ms 
pulses are less likely to suffer from injuries since the relationship between defibrillation 
probability and pacing threshold was lower for this duration, indicating that the impair-
ment is smaller because the induced potential is lower in this case.
This outcome, along with a greater stimulatory safety factor for the duration of 0.5-ms 
[12], supports the hypothesis that a defibrillatory shock with this duration would be bet-
ter for reversing VF in rats. Still, further studies should be performed to identify possible 
mechanisms underlying this finding.
Materials and methods
The protocols for animal care and use were approved by the Institutional Committee for 
Ethics in Animal Research (IB/UNICAMP, No. 4355-1). All the animals received care in 
accordance with relevant guidelines and regulations.
Isolated heart preparation
Ten male Wistar rats with age ranging from 5 to 6  months and average weight of 
535.3  g ± 6.4  g were used. The animals received intraperitoneal injection of sodium 
heparin (3000 IU/kg), and they were anesthetized with an anesthetic button of lidocaine 
(5 mg/kg) and with an intraperitoneal injection of thiopental sodium (80 mg/kg). Fol-
lowing the chest opening, the heart was quickly and carefully excised. The aorta was 
cannulated in a Langendorff-adapted preparation (Fig.  7), where the heart was retro-
gradely perfused with Krebs–Henseleit solution composed of salts with the following 
concentrations (mM): NaCl 115,  NaHCO3 25, KCl 4.6,  MgSO4 1.2  KH2PO4 1.2, glucose 
11.0 and  CaCl2 1.4, constantly carbonated with carbogen mixture (5%  CO2 and 95%  O2) 
to maintain the pH between 7.35 and 7.45, and heated to 37 °C ± 0.5 °C.
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Experimental protocol
After cannulation, the hearts were housed in the internal reservoir of the stimulation 
chamber (Fig. 7), heated (37 °C) by hot water circulation in the external reservoir pro-
vided by a pump (developed and manufactured by the Center for Biomedical Engineer-
ing, Campinas, Brazil). The heart was positioned in the middle of the chamber, 4  cm 
distant from the parallel plates located on the sides of the stimulation chamber, i.e., the 
stimulation electrodes, what allowed a uniform distribution of HEF within the chamber 
[33], which can be calculated according to the following equation [34]:
where E is the electric field module, I is the current flowing through the chamber, σ is the 
physiological solution conductivity, h is the submerged height of the electrodes and w is 
the electrode width. In our setup, the conductive bath had 3.9 cm height (h) per 10.0 cm 
width (w), constituting a total volume of 152 ml and calculated resistance of 45.06 Ω. 
The Krebs–Henseleit solution σ was assumed to be 0.014 S/cm [34].
After 10  min for heart rate stabilization, the cardiac electrophysiological signal 
(ECG) was captured by Ag/AgCl electrodes (ECG electrodes), amplified (gain = 2000) 
and filtered (high-pass filter: fch = 3 Hz; low-pass filter: fcl = 100 Hz) by a electrophysi-
ological signal amplifier (developed and manufactured by the Center of Biomedical 
Engineering, Campinas, Brazil). The ECG trace was visualized in an oscilloscope 
(manufactured by Tektronix Inc. Beaverton, OR, USA, model TDS 2014C, 100 MHz 
bandwidth) (Fig.  7). The spontaneous heart rate was determined by measuring the 
interval between five ECG R-waves.
Stimulation electrodes were connected to a low-intensity electrical stimulator (LIS, 
developed and manufactured by Center for Biomedical Engineering, Campinas, Bra-
zil). The pacing threshold was determined for seven pulse durations (0.2-, 0.5-, 1-, 3-, 
(2)E =
I
σ · h · w
,
Fig. 7 Experimental setup diagram. VED is the video edge detector, LIS is the low-intensity stimulator and 
the HIS is the high-intensity stimulator
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5-, 8- and 10-ms, total wave duration). The pulse duration sequence was randomly 
chosen for each heart and the stimulus frequency was set to 20% above the meas-
ured spontaneous heart rate. The stimulus amplitude was increased until the heart 
rate was equalized with the stimulation rate; the heart rate was inferred through the 
use of a video signal edge detector (VED, developed and manufactured by the Center 
for Biomedical Engineering, Campinas, Brazil). VED was coupled to a video camera 
(Ikegami Tsushinki Co., LTD, Japan—ICD-31 mod.) and to a video monitor (Kodo 
Electronics Co, LTD, Seoul, Korea—mod. KBM1200S, Fig. 7). The voltage output of 
the VED was proportional to the displacement of the heart border. When the electri-
cal output signal of the VED synchronized with the stimulatory pulses, we considered 
that the heart was being paced. The minimum electric field (E) that kept the synchro-
nism was considered the ET. This protocol was repeated for each stimuli duration.
The fibrillator (developed and manufactured by the Center for Biomedical Engi-
neering Center, Campinas, Brazil) was coupled to the stimulation electrodes and the 
VF was induced by delivering a sine wave signal, with 60  Hz, amplitude from 1 to 
3 V/cm and duration from 0.5 to 2  s [10, 35]. Duration and stimuli amplitude were 
adjusted to induce VF which was detected by monitoring the ECG record. When VF 
was maintained for at least 2 min, it was considered sustained and the fibrillator was 
disconnected; otherwise, a new amplitude and duration combination was set and VF 
was re-induced.
Once sustained VF was confirmed, the defibrillation protocol was started. A high-inten-
sity electrical stimulator (HIS, developed and manufactured by the Center for Biomedical 
Engineering, Campinas, Brazil) was coupled with the stimulation electrodes and a monop-
olar electrical stimuli was applied with the truncated exponential waveform (decay less than 
10%, with variable voltage from 1 to 1000 V and duration from 0.2- to 10-ms). The pulse 
duration was randomly chosen and the amplitude was initially set to five times the ET for 
the chosen duration of the same heart. This procedure was repeated for stimuli amplitudes 
between 10 and 35 times ET, or until defibrillation was confirmed, i.e., return of a clear QRS 
complex on the ECG record combined with heart contraction (Fig. 8, square A shows a case 
Fig. 8 Defibrillation evaluation. Electrocardiogram analysis after defibrillatory pulse application. a 
Defibrillation failure (the signal between 2 and 2.2 s was caused by the defibrillatory pulse application) and b 
defibrillation success (the signal between 1.3 and 1.45 s was caused by the defibrillatory pulse application)
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of defibrillation failure, and square B shows a case of success). For each heart, the proce-
dures for fibrillation and defibrillation were performed once for each pulse duration, with 
intervals of 5 min to stabilize heart rate. The sequence of pulses with different durations 
was randomly chosen for each heart.
Statistical analysis
Defibrillation probability curves were based on the relationship between defibrillation 
probability and applied HEF in V/cm and ×Threshold (HEF values applied normalized to 
ET) by survival analysis [36]. The curves obtained were compared by the Mantel–Cox test 
and adjusted by the following equation:
where L is defibrillation probability,  HEF50 is the average value of HEF corresponding to 
50% of defibrillation probability and h is the Hill coefficient [14].  HEF50 values in V/cm 
and ×Threshold for each duration were compared by F test.
Two SxD curves were obtained: pacing SxD curve was made with ET values and the defi-
brillation probability SxD curve was plotted with the average values of  HEF50, in V/cm 
obtained from the survival analysis. Both SxD curves were adjusted by Weiss–Lapicque 
equation (Eq. 1).
The ratio of defibrillation probability to pacing threshold was plotted with the average 
values of  HEF50, in ×Threshold obtained from the survival analysis.
Statistical significance index α adopted for all tests was 0.05. All analyses and tests were 
made with the software Prism 5.03 (GraphPad Software, San Diego, US).
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